Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale SVP, Finance and Accounting sold 1,990 shares at $1.38 ($2,747)
  2. 4 Option exercise SVP, Finance and Accounting acquired 6,875 shares (option exercise)
  3. 4 Option exercise CEO acquired 37,500 shares (option exercise)
  4. 4 Option exercise Chief Business Officer acquired 11,250 shares (option exercise)
  5. 4 Option exercise General Counsel acquired 11,250 shares (option exercise)
  6. 4 Option exercise SVP, Chief Scientific Officer acquired 11,250 shares (option exercise)
  7. 4 Open-market sale SVP, Chief Scientific Officer sold 4,119 shares at $1.30 ($5,356)
  8. 4 Open-market sale Chief Business Officer sold 4,119 shares at $1.30 ($5,356)
  9. 4 Open-market sale CEO sold 14,601 shares at $1.30 ($18,987)
  10. 4 Open-market sale General Counsel sold 5,486 shares at $1.30 ($7,135)
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Option exercise CEO acquired 16,535 shares (option exercise)
  20. 4 Open-market buy Director bought 5,000 shares at $1.55 ($7,750)

Page 5 of 20 · 400 filings